Detection of Immunoglobulin G to Poliovirus in Children 5-10 Years Old in Minna, Nigeria
Digital Object Identifier:
10.58578/ajstea.v2i2.2720
Viewed : 82 times
Downloaded : 60 times
Please do not hesitate to contact us if you would like to obtain more information about the submission process or if you have further questions.
Abstract
In the Minna, data on the seroprevalence rate of antibodies to poliovirus serotypes which can be used to determine children’s immune status and the vaccine efficacy against poliomyelitis is sparse. This study aim was to detect immunoglobulin G to poliovirus in children aged 5-10 years old in Minna, Nigeria. About 2 mL of blood was collected by venipuncture from 91 children selected randomly from various health care facilities across Minna. Blood samples were centrifuged to obtain the sera. The detection of poliovirus specific immunoglobulin G (IgG) was done using polyclonal Enzyme linked immunosorbent assay (ELISA) detection test kits. In this study, all the children had detectable level of antibodies, 85 (93.4%) children consisting of 49 (53.8%) males and 36 (39.6%) females showed protective level of antibodies (seropositive). Seropositivity rate of 96.8% (30/31), 94.0% (31/33) and 88.9% (24/27) was recorded among children aged 9-10, 7-8 and 5-6 years old respectively. About 74.7% (68/91) of the participants were weak responder (concentration of antibodies <50 U/mL) to the vaccines received with low seroconversion rates while 6.6% (6/91) of the children had sub-protective level of antibodies (seronegative). Age, sex, parents’ occupation, mothers’ educational status and drinking water source had no significant association (p>0.05) with seroprevalence rates while fathers’ educational status showed significant statistical association with seroprevalence rate (p<0.05). High seropositivity was recorded in this study, nation-wide seroprevalence is recommended to comprehensively evaluate the progress made so far in sustaining polio-free status.
Citation Metrics:
Downloads
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Adeniji, A.J., Onoja, A.B., & Adewumi, M.O. (2015). Polio virus neutralizing antibody dynamics among children in a North-Central and South-Western Nigeria State. Journal of Immunoassay and Immunochemistry, 36(1), 45-53. https://doi.org/10.1080/15321819.2014.893889
Adewumi, M.O., Donbraye, E., Odaibo, G.N., Bakarey, A.S., Opaleye, O.O., & Olaleye, D.O. (2006). Neutralizing antibodies against poliovirus serotypes among children in South West Nigeria. Journal of Tropical Pediatrics, 52(2), 92-95. https://doi.org/10.1093/tropej/fmi075
Alattas, S.G. (2017). Immunological evaluation of sequential poliovirus vaccination among Saudi and non-Saudi children living in Jeddah. African Journal of Microbiology Research, 11(29), 1150-1154. https://doi.org/10.5897/AJMR
Aliya, N., Shah, S.S.A., Jaffery, S.I.A., Ahmed, S.A., Khan, M.A.B & Aslam, M. (2015). Seroprevalence rate of poliovirus antibodies among the healthy and protein energy malnutrition children. Pakistan Journal of Medical Science, 31(2), 403-407.
Alleman, M.M., Wannemuehler, K.A., Weldon, W.C., Kabuayi, J.P., Ekofo, F., Edidi S, Mulumba, A., Mbule, A., Ntumbannji, R.N., Coulibaly, T., Abiola, N., Mpingulu, M., Sidibe, K. & Oberste, M.S. (2014). Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment. Journal of Infectious Disease, 210(11), S62-73. https://doi.org.10.1093/infdis/jiu282.
Aminu, A.I., Aliyu, F.A., Mukhtar, M.D., Gajida, A.U. & Aminu, M. (2017). Detection of polio virus antibodies level among children in Kano State, Nigeria. International Journal of Advance Research, 5(5), 1988-1998. http://dx.doi.org/10.21474/IJAR01/4339
Arvas, A. (2014). Vaccination in patients with immunosuppression. Turkish Archives of Pediatrics, 49(3), 181-185. https://doi.org/10.5152/tpa.2014.2206
Babatunde, O. A., Olatunji, M. B., Omotajo, O. R., Ikwunne, O. I., Hamzat, Z., & Sola, S. T. (2020). A comparative assessment of cold chain management using the outbreak of circulating vaccine-derived polio virus type 2 as a surrogate marker in Oyo State, Nigeria-2019. Pan African Medical Journal, 37(313). https://doi.org/10.11604/pamj.2020.37.313.26152.
Baicus, A. (2012). History of polio vaccination. World Journal of Virology, 1(4), 108-114. https://doi.org/10.5501/wjv.v1.i4.108.
Bandyopadhyay, A.S., Garon, J., Seib, K., & Orenstein, W.A. (2015). Polio vaccination past, present and future. Future Microbiology, 10(5), 791-808. https://doi.org/10.2217/fmb.15.19
Blake IM, Martin R, Goel A, Khetsuriani N, Everts J, Wolff, C., Wassilak, S., Aylward, R.B. & Grassly, N. C. (2014). The role of older children and adults in wild poliovirus transmission. Proceedings of the National Academy of Sciences USA, 111(29), 10604-10609. https://doi.org/10.1073/pnas.1323688111
Bulama, A. A., & Goodman-Brown, J. (2019). Polio eradication in Nigeria and India: a systematic review of challenges and successes. International Journal of Translational Medical Research and Public Health, 3(2), 83-94. https://doi.org/10.21106/ijtmrph.92
CDC (2021, April 20). Vaccine storage and handling toolkit. Updated with COVID-19 vaccine storage and handling information. Retrieved from: https://www.cdc.gov» adminPDF vaccine storage and handling toolkit - CDC
CDC, (2020). Africa kicks out wild polio, Global Immunization [internet]. Centre for Disease Control and Prevention; 2020. Retrieved from https://stacks.cdc.gov/view/cdc/95754
Dairo, D.M. & Osizimete, O.E. (2016). Factors affecting vaccine handling and storage practices among immunization service providers in Ibadan, Oyo State, Nigeria. African Health Sciences, 16(2), 576-583. https://doi.org/10.4314/ahs.v16i2.27
Dashe, N., Banwat, E. B., Dimas, D., Agabi, Y. A. & Enenebeaku, M. (2010). Polio-Specific Immunoglobulin G Antibodies among Children in Jos, Nigeria. Shiraz Egyptian Medical Journal, 11(4), 183–190.
Demeditec Diagnostics GmbH (2021, January 17). Demeditec poliomyelitis virus IgG ELISA DEPOL01. Version 5/JS Updated 20150130. Retrieved from: http://www.demeditec.com
Donbraye, E., Adewumi, M. O., Odaibo, G. N., Bakarey, A. S., Opaleye, O. O. & Olaleye, D. O. (2011). Evaluation of immunity against poliovirus serotypes among children in riverine areas of Delta State, Nigeria. African Journal of Clinical and Experimental Microbiology, 12(2), 72-75. https://doi.org/10.4314/ajcem.v12i2.64321
Duintjer-Tebbens, R. J., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., Patriarca, P. A., Sutter, R. W., Wright, P. F., Wassilak, S. G. F., Cochi, S. L., Kim, J. & Thompson, K. M. (2013). Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs. Risk Analysis, 33, 4. https://doi.org/10.1111/risa.12031
Famulare, M., Selinger, C., McCarthy, K. A., Eckhoff, P. A., & Chabot-Couture, G. (2018). Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. PLoS Biology, 16(4),e2002468. https://doi.org/10.1371/journal.pbio.2002468
Giwa, F. J., Olayinka, A. T. & Ogunshola, F. T. (2012). Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. Vaccine, 30(48), 6759-6765. https://doi.org/10.1016/j.vaccine.2012.09.023
GPEI. (2021). Global overview - status of polio eradication. Information note for the special focus session on polio. 2021 Annual session of the UNICEF executive board 1 to 4 June, 2021. Retrieved from: polioeradication.org
Jia, S., Tang, R., Li, G., Hu, Y., & Liang, Q. (2020). The effect of maternal poliovirus antibodies on the immune response of infants to poliovirus vaccines. Bio Medical Centre Infectious Diseases, 20, 641(2020). https://doi.org/10.1186%2Fs12879-020-05348-1
John, T. J., Sutter, W. R., & Mach, O. (2013). Poliomyelitis. International Encyclopedia Public Health, 509-518.
Konopka-Anastadt, J. L., Campagnoli, R., Vincent, A., Shaw, J., Wei, L., Wynn, N. T., Smithee, S. E., Bujaki, E., Yeh, M. T., Lassri, M., Zagorodnyaya, T., Weiner, A. J., Chumakov, K., Andino, R., Macadam, A., Kew, O., & Burns, C. C. (2020). Development of a new oral poliovirus vaccine for the eradication, end game using codon deoptimization. Nature Partner Journals Vaccines, 5, 26(2020). https://doi.org/10.1038/s41541-020-0176-7
Li, J., Zhang, Z., Zhang, H., Li, M., Li, X., Lu, L., Huang, F. & Wu, J. (2021). Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing. Human Vaccines & Immunotherapeutics, 17(2), 389-396. https://doi.org/10.1080/21645515.2020.1778409
Magrath, D., Bainton, D., & Freeman, M. (1981). Response of children to a single dose of oral or inactivated polio vaccine. Developments in Biological Standardization, 47, 223–226.
Yusuf K.M., Jatau, D.E., Olonotola, S, Yakubu, E., Suleiman, A.B., Nuhu, A., Zubairu, G. & Yahaya, A.E. (2015). Rapid assessment of polio virus antibodies prevalence amongst children in Kano State, North West Nigeria. Science World Journal, 10(2), 13-17.
Mehndiratta, M. M., Mehndiratta, P., & Pande, R. (2014). Poliomyelitis: Historical facts, epidemiology and current challenges in eradication. Neurohospitalist, 4(4), 223-229. https://doi.org/10.1177/1941874414533352
Ming, L. C., Hussain, Z., Yeoh, S. F., Koh, D., & Lee, K. S. (2020). Circulating vaccine derived poliovirus: a menace o the end game of polio eradication. Globalization and Health, 16, 63. https://doi.org/10.1186/s12992-020-00594-z
Ngowi, H.A., Mlangwa, J.E.D., Carabin, H., Mlozi, M.R.S., Kassuku, A.A., Kimera, S.I. & Willingham, A.L. (2007). Financial efficiency of health and pig management education intervention in controlling porcine cysticercosis in Mbulu District, northern Tanzania. Livestock Research for Rural Development, 19(62), 78. Retrieved from http://www.lrrd.org/lrrd19/5/ngow19062.htm
Nicholson, L. B. (2016). The immune system. Essays in Biochemistry, 60(3), 275-301. https://doi.org/10.1042/ebc20160017
Niewiesk S. (2014). Maternal antibodies: clinical significance, mechanism of interference with immune responses and possible vaccination strategies. Frontier Immunology, 5, 446.
Nishio O, Ishihara Y, Sakae K, Nonomura Y, Kuno A, Yasukawa S, Yasukawa, S., Inoue, H., Miyamura, K. & Kono, R. (1984). The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. Journal of Biological Standardization, 12(1), 1-10. https://doi.org/10.1016/s0092-1157(84)80015-3
Oladejo, O.P.G., Nwobu, O.P., Omosigho, M., Baba, S., Oderinde, E.E.G., Otojareri K.A., Ndako, J., Ogedengbe, S. O. & Onoja, A. O. (2013). Neutralization antibodies in oral poliovirus vaccine (OPV) vaccinated children and young adult in Bida North Central, Nigeria. International Journal of Epidemiology and Infection, 1(2), 19-24. https://doi.org/10.12966/ijei.07.03.2013
Opare, J.K.L., Odoom, J.K., Akweongo, P., Afari, E.A. & Pappoe, M. (2019). Poliovirus antibody levels and lameness among individuals in three regions of Ghana. Human Vaccines & Immunotherapy. https://doi.org/10.1080/21645515.2019.1637235.
Patriarca, P., Wright, P.F. & John, T.J. (1991). Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Reviews of infectious diseases, 13(5), 926-939. https://doi.org/10.1093/clinids/13.5.926.
Pollard, A. J., & Bjiker, E. M. (2021). A guide to vaccinology: from basic principles to new developments. Nature Reviews Immunology, 21, 83-100. https://doi.org/10.1038/s41577-020-00479-7
Richard, A., Kaslow, R., Lawrence, R. S., James, W., & Le, D. (2014). Viral infections of humans: Epidemiology and control. Springer; Pp. 294.
Roberts, L. (2018). Alarming polio outbreak spreads in Congo, threatening global eradication efforts. Science. https://doi.org/10.1126/science.aau6493
Scherbel-Ball, N. (2020, August 25). Africa declared free of wild polio in milestone. BBC News. Retrieved from https://www.bbc.com/news/world-africa-53887947
Shehu, A. & Awa-Agwu, E. (2019, August 19). Supporting access to immunization through supplementary immunization activities. Ehealth Africa, GIS & data Analytics, Health Delivery systems, Public Health Emergence. Retrieved from https://www.ehealthafrica.org/blog/2019/8/19/supporting-access-to-immunization-through-supplementary-immunization-activities
Tao, W., Petzold, M. & Forsberg, B.C. (2013). Routine vaccination coverage in low-and middle-income countries: further arguments for accelerating support to child vaccination services. Global Health Action, 6(1), 20343. https://doi.org/10.3402/gha.v6i0.20343
The Lancet Global Health (2020). Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Health Policy, 8(10), E1345-E1351. https://doi.org/10.1016/S2214-109X(20)30382-X
Thompson, K. M., Pallansch, M. A., Duintjer-Tebbens, R. J., Wassilak, S. G., Kim, J. H., & Cochi, S. L. (2013). Pre-eradication vaccine policy options for poliovirus infection and disease control. Risk Analysis, 33, 516–543. https://doi.org/10.1111/risa.12019
Wanjiku, H.W., & Adetifa, I.M.O. (2018). Serological surveys for complementing assessments of vaccination coverage in sub-Saharan Africa: A systematic review. Wellcome Open Research, 3,16. https://doi.org/10.12688/wellcomeopenres.13880.1
Wood, N., & Thorley, B. (2003). Towards global poliomyelitis eradication: the successes and challenges for a developed country. Journal Paediatrics and Child Health, 39(9), 647-650. https://doi.org/10.1046/j.1440-1754.2003.00263.x.
UNICEF (2020, August 25). WHO and UNICEF congratulate Nigeria on ending wild poliovirus; call for strengthening of routine immunization. World Health Organisation; 2020. Retrieved from https://www.unicef.org/nigeria/press-releases/who-and-unicef-congratulate-nigeria-ending-wild-poliovirus-call-strengthening#:~:text=WHO%20and%20UNICEF%20today%20congratulated,vaccinated%20against%20vaccine%2Dpreventable%20diseases.
World Population Review (2021). Minna Population. Retrieved from: https://wporldpopulationreview.com/world-cities/minna-population
Yu, W.Z., Wen, N., Zhang, Y., Wang, H.B., Fan, C.Z., Zhu, S.L., Xu, W. B., Liang, X.F., Luo, H.M. & Li, L. (2014). Poliomyelitis eradication in China: 1953-2012. Journal of Infectious Disease, 210(1), S268-S274. https://doi.org/10.1093/infdis/jit332
